1. Home
  2. STTK vs PNRG Comparison

STTK vs PNRG Comparison

Compare STTK & PNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.18

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

PNRG

PrimeEnergy Resources Corporation

HOLD

Current Price

$220.30

Market Cap

307.4M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
PNRG
Founded
2016
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
307.4M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
STTK
PNRG
Price
$6.18
$220.30
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$7.60
N/A
AVG Volume (30 Days)
617.5K
30.2K
Earning Date
03-05-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
53.02
103.81
EPS
N/A
9.43
Revenue
$1,000,000.00
$237,796,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$23.03
Revenue Growth
N/A
79.05
52 Week Low
$0.69
$126.40
52 Week High
$6.27
$238.20

Technical Indicators

Market Signals
Indicator
STTK
PNRG
Relative Strength Index (RSI) 73.59 66.89
Support Level $1.85 $159.14
Resistance Level N/A N/A
Average True Range (ATR) 0.42 9.19
MACD 0.05 1.02
Stochastic Oscillator 93.80 82.24

Price Performance

Historical Comparison
STTK
PNRG

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About PNRG PrimeEnergy Resources Corporation

PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and providing well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.

Share on Social Networks: